After extensive
conversations over the
past several
weeks with senior staff persons and key Members of Congress who serve on the congressional committees with jurisdiction over the bill, it has become clear that very
few, if any, public health bills such as the SMA Treatment Acceleration Act will move through Congress
during the lame - duck session set to begin on November 15.